MedTrace Logo

Intravascular Access in Suspected/Confirmed COVID-19 Patient

NCT04366947 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-12-19

No results posted yet for this study

Summary

The current COVID-19 pandemic, this is especially since the transmission of SARS-CoV-2 is thought to occur mainly through respiratory droplets generated by coughing and sneezing, by direct contact with contaminated surfaces and because in a large number of patients COVID-19 disease may be asymptomatic. As recommended by the CDC medical personnel should be equipped with full personal protective equipment (PPE) for AGP in contact with suspected/confirmed COVID-19 patient. Therefore, it is reasonable to search for the most effective methods of intravascular access in those conditions.

Conditions

  • Emergency Medicine
  • Cardiopulmonary Arrest
  • Shock

Interventions

DEVICE

NIO® (Intraosseous access)

obtaining intravascular access using a ready intravenous NIO needle set

DEVICE

Standard of Care (Intravenous access)

obtaining intravascular access using a standard intravenous cannula

Sponsors & Collaborators

  • Poznan University of Medical Sciences

    collaborator OTHER

  • Medical University of Bialystok

    collaborator OTHER

  • Wroclaw Medical University

    collaborator OTHER

  • Lazarski University

    lead OTHER

Principal Investigators

  • Lukasz Szarpak, PhD · Lazarski University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-14
Primary Completion
2020-09-20
Completion
2020-10-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04366947 on ClinicalTrials.gov